ARCHIVES

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

AACR, Kellogg’s Co. Sponsor Award

January 5, 1996